Huameng Li
- Topics
- Cytokine Signaling Pathways and Interactions (8 papers)Inflammatory mediators and NSAID effects (4 papers)Computational Drug Discovery Methods (3 papers)
- Cited by
- OncologyToxicologyMolecular Medicine
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Huameng Li
18 papers receiving 930 citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 417
- Oncology 335
- Plant Science 182
- Immunology 143
- Pathology and Forensic Medicine 104
Countries citing papers authored by Huameng Li
This map shows the geographic impact of Huameng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huameng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huameng Li more than expected).
Fields of papers citing papers by Huameng Li
This network shows the impact of papers produced by Huameng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huameng Li. The network helps show where Huameng Li may publish in the future.
Co-authorship network of co-authors of Huameng Li
This figure shows the co-authorship network connecting the top 25 collaborators of Huameng Li. A scholar is included among the top collaborators of Huameng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huameng Li. Huameng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 50 | |
| 2 | 36 | |
| 3 | 14 | |
| 4 | 83 | |
| 5 | 198 | |
| 6 | 28 | |
| 7 | 128 | |
| 8 | Multiple Ligand Simultaneous Docking (MLSD) and Its Applications to Fragment Based Drug Design and Drug Repositioning | 4 |
| 9 | 0 | |
| 10 | 54 | |
| 11 | 26 | |
| 12 | 66 | |
| 13 | 41 | |
| 14 | 48 | |
| 15 | 7 | |
| 16 | 23 | |
| 17 | 48 | |
| 18 | 78 | |
| 19 | 14 |
About Huameng Li
Huameng Li is a scholar working on Molecular Medicine, Pharmacology and Oncology, having authored 19 papers that have together received 946 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (8 papers), Inflammatory mediators and NSAID effects (4 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Oncology (335 citations), Toxicology (41 citations) and Molecular Medicine (57 citations). Huameng Li has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Jiayuh Lin, Chenglong Li, Guang Liang, Shulin Yang, Chengguang Zhao, Huey‐Jen Lin, David Jou, Hui Xiao, Chenglong Li and Aiguo Liu. Their work appears in journals such as PLoS ONE, PLANT PHYSIOLOGY and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.